Skip to main content

Table 2 Energy, macronutrient and micronutrient intake at baseline and postintervention

From: The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes

VariablesDill powder (n = 21)Placebo (n = 21)P valueaP valueb
Energy (kcal)
 Baseline1881 ± 1611796 ± 1670.1000.113
 End1861 ± 1761811 ± 1630.3390.257
P valuec0.4120.593  
Carbohydrate (g)
 Baseline249.61 ± 23.19240.40 ± 20.460.1800.146
 End246.51 ± 23.61238.23 ± 14.280.1790.113
P valuec0.2700.536  
Protein (g)
 Baseline75.41 ± 6.1573.43 ± 6.090.3030.240
 End74.61 ± 5.7272.04 ± 6.650.1870.145
P valuec0.2100.135  
Fat (g)
 Baseline61.53 ± 5.3759.66 ± 4.740.2410.196
 End60.26 ± 6.2461.93 ± 4.320.1690.098
P valuec0.1470.113  
Vitamin A (U)
 Baseline377.38 ± 103.76321.32 ± 85.710.0640.034*
 End368.66 ± 115.02352.93 ± 88.030.6220.693
P valuec0.7790.159  
Vitamin C (mg)
 Baseline87.03 ± 27.8791.36 ± 29.580.6280.744
 End91.44 ± 30.9296.85 ± 32.200.5820.633
P valuec0.5920.541  
Vitamin E (mg)
 Baseline2.03 ± 0.722.38 ± 0.850.1660.205
 End1.85 ± 0.522.12 ± 0.630.1460.136
P valuec0.1710.095  
  1. Values are expressed as means ± standard deviation
  2. *P < 0.05 considered as significant, and significant values are shown in bold type
  3. aBetween-group comparison of variables at baseline and after intervention from independent t test (for all variables)
  4. bBetween-group comparison of variables at baseline and after intervention from analysis of covariance in the adjusted models (adjusted for age, duration of disease and body mass index)
  5. cWithin-group comparison of variables from paired sample t test (for all variables)